By Gary Pepper, M.D.
A survey by metabolism.com reveals that a vast majority of the public believe doctors in the US are overly influenced in their decisions by the pharmaceutical industry. 500 visitors to the website participated in the survey. 419 (84%) answered yes to the question, “Do you feel that US doctors’ decisions are overly influenced by pharmaceutical industry money?” 56 (11%) were not sure, and only 20 (4%) voted no to this question. Continue reading
by Dr. S. Brown
Less than a year ago, Glaxo-SmithKline made a public pledge to stop using physicians as paid promoters of their pharmaceutical products. Now, with the release of their new diabetes product, Tanzeum, GSK also released a list of 168 freshly minted physician lecturers, specifically trained to promote the new drug.
As of yet, no other company has joined in the effort to clean up physician marketing of new drug products. Perhaps it became clear to the pharmaceutical giant that using doctors to promote their products was just too successful a tactic to give up, particularly if the competition refused to abide by the new rules.
Coincidentally, in the 2014, September 2 issue of the Annals of Internal Medicine (Ann Int Med 2014; 161 (5): 363-363), Jerry Avorn, M.D. of Harvard University, authored an opinion piece Continue reading